NDC 10107-0250-20 — WartStick Salicylic Acid .4 g/g Stick, 1 tube

🆔 Identity & classification

FDA NDC (as labeled) 10107-250-20

Product NDC 10107-250

11-digit billing NDC 10107025020

RxCUI 251407, 2043252

UNII O414PZ4LPZ

UPC 0083467248000, 0083467252250, 0083467246242, 0083467251253

Application # M028

SPL Set ID 6ffae85f-7ada-4350-9cd5-0396ea4d9314

DEA schedule Non-controlled

Marketing category OTC MONOGRAPH DRUG

Marketing status On market

FDA listing status Listed (active directory)

Marketing start 1983-06-01

Route TOPICAL

Dosage form STICK

Substance SALICYLIC ACID

Why two NDCs? The FDA registers this code as 10107-250-20 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 10107-0250-20. Same drug, same package — only the format differs.

Where does this data come from?

Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids

Where does this data come from?

Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerBalassa Laboratories Inc.

FDA applicationM028 (OTC MONOGRAPH DRUG)

Labeler code10107

First marketedJun 1983

Product typeHuman Otc Drug

Portfolio7 products on file

🔎 All NDCs from Balassa Laboratories Inc.

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).

Where does this data come from?

Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist

It's designed to treat acne. Salicylic acid helps by loosening and removing dead skin cells that clog pores — the buildup that leads to breakouts. The multi-step system on this lab...
What is this salicylic acid product actually supposed to do for my skin?
Some mild tingling, stinging, and peeling is actually expected — that's the salicylic acid doing its job by clearing away dead skin cells. But if the burning or peeling feels exces...
My skin feels like it's burning and peeling. Is that normal?

📖 Read our full Salicylic Acid Topical guide →

Patient education

📘 MedlinePlus patient leaflet ↗

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →

Where does this data come from?

Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color yellow

One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.

Where does this data come from?

Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.

Where does this data come from?

Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?

No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.

Why might an inactive ingredient be missing?

Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.

Can inactive ingredients matter?

Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price system	Per each	Per package
Retail pharmacies payNADAC · weekly	Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo	No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly	No Part D plan price is available for this NDC in our data.

ℹ️

No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.

Try another pack size: 5.1 g 5.1 g 5.1 g 2 tubes

Where does this data come from?

NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

Product	Labeler	Pack	NADAC/unit	TE	Status	Price vs. this
CornStick .4 g/g 10107-0240-02	Balassa	1 tube	—	—	FDA listed	—
WartStick .4 g/gthis 10107-0250-20	Balassa	1 tube	—	—	FDA listed	—
WartStick Plantar .4 g/g 10107-0251-02	Balassa	1 tube	—	—	FDA listed	—
Propolis Wart Remover Stick 40 g/100g 83004-0029-01	Rida	1 tube	—	—	FDA listed	—
SupreH Solid Wart Remover Stick 40 g/1001 83818-0027-01	Shenzhen	2 sticks	—	—	FDA listed	—
Salicylic Acid 40% / Corn Remover .4 g/g 51511-0599-12	ASO	16800 patches	—	—	FDA listed	—
Scholls Wellness Company LLC Duragel Callus Remover .4 g/g 73469-0644-01	Scholls	4 pouches	—	—	FDA listed	—
Scholls Wellness Company LLC One Step Corn Removers .4 g/g 73469-0753-01	Scholls	6 pouches	—	—	FDA listed	—
One Step Wart Removers .4 g/g 73469-6321-04	Scholls	14 pouches	—	—	FDA listed	—
Scholls Wellness Company LLC DURAGEL CORN REMOVER .4 g/g 73469-0627-01	Scholls	6 pouches	—	—	FDA listed	—
Clear Away Wart Removers .4 g/g 73469-6421-02	Scholls	12 pouches	—	—	FDA listed	—
Plantar Wart Removers .4 g/g 73469-6331-02	Scholls	12 pouches	—	—	FDA listed	—
Compound W Corn Remover .4 g/g 63029-0599-08	Medtech	8 patches	—	—	FDA listed	—
Scholls Wellness Company LLC DS EXTRA THICK CALLUS REMOVER .4 g/g 73469-0463-01	Scholls	4 pouches	—	—	FDA listed	—

About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.

Where does this data come from?

Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️

1983

On the market since

Jun 1983

📍

2026

Currently FDA-listed

43 years listed

🔒

·

No generic listed yet

brand only

ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?

Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.

⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.

Period

Total Part D spend

$11.2K

Claims incl. refills

43

Beneficiaries

35

Spend / beneficiary

$319.01

Spend / claim

$259.66

Trend by period

💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

📦 Packaging — all sizes for this product

Package NDC	Description	Marketing start	Status
10107-0250-02	1 TUBE in 1 CARTON (10107-250-02) / 5.1 g in 1 TUBE (10107-250-01)	2017-05-12	Active
10107-0250-03	2 TUBE in 1 CARTON (10107-250-03) / 5.1 g in 1 TUBE (10107-250-01)	2017-03-13	Active
10107-0250-08	1 TUBE in 1 CARTON (10107-250-08) / 5.1 g in 1 TUBE (10107-250-01)	2018-08-23	Discontinued by firm
10107-0250-20 You're viewing this	1 TUBE in 1 KIT (10107-250-20) / 5.1 g in 1 TUBE (10107-250-01)	2024-10-01	Active
10107-0250-21	1 TUBE in 1 KIT (10107-250-21) / 5.1 g in 1 TUBE (10107-250-01)	2024-10-01	Active

Pack size FAQ

What quantity is in NDC 10107-0250-20?

NDC 10107-0250-20 contains 1 tube — 1 tube in 1 kit / 5.1 g in 1 tube.

What is the difference between NDC 10107-0250-20 and NDC 10107-0250-02?

Both are WartStick Salicylic Acid .4 g/g Stick — the drug itself is identical. NDC 10107-0250-20 is the 1 tube package, while NDC 10107-0250-02 is the 1 tube package.

What NDC number is used to bill for this package of WartStick Salicylic Acid .4 g/g Stick?

Bill NDC 10107-0250-20 — the 11-digit billing format is 10107025020. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Kit / multi-component package

Kit / multi-component package

This NDC identifies a kit — a package containing more than one component. Structured data (pricing, ingredients, equivalents) is often reported per component rather than for the kit NDC itself, which can make this page look thinner than the components' own pages.

What data is (and isn’t) available for this NDC — tap to expand

NDC identity (package / product / labeler codes)	✓ Available
Labeler	✓ Available
Product & package description	✓ Available
Marketing category & status	✓ Available
Active ingredient / dosage form / route	✓ Available
FDA label (SPL via DailyMed)	✓ Available
Package photos	✓ Available
Inactive ingredients (structured)	— Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS)	— Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data	— Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk	— Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD)	— Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.

“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?

An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.

Why is there no price listed?

The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.

Is the NDC printed on the package the same as the 11-digit billing NDC?

Yes, they identify this exact package in different formats. The FDA registers it as 10107-250-20, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 10107-0250-20, written without dashes as 10107025020. The Identity section at the top of this page lists every form of this code.

What do the three segments of this NDC mean?

In 10107-0250-20, the first segment (10107) is the labeler code FDA assigned to Balassa Laboratories Inc.; the middle segment (0250) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (20) identifies this exact package size and type. Together they name one specific package of one specific product.

Is this package still being marketed?

Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Balassa Laboratories Inc.. Listing status can change — the directory data on this page refreshes weekly.

Does this product come in other package sizes?

Yes — the FDA directory lists 4 other package presentations of this same product, including 1 tube (10107-0250-02), 1 tube (10107-0250-08), 1 tube (10107-0250-21). Each has its own NDC and its own page — see the package list near the top of this page.

Who lists this product with the FDA?

Balassa Laboratories Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.

Do I need a prescription for this product?

This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.

This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.

Where does this data come from?

Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.

🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose

🎯 Indications and Usage 51 words ▾

Uses For the removal of common warts. The common wart is easily recognized by the rough "cauliflower-like" appearance of the surface. For the removal of plantar warts. The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.

⏱️ Dosage and Administration 52 words ▾

Directions Wash affected area May soak in warm water for 5 minutes Dry area thoroughly Keeping the product off the surrounding skin, apply a thin layer of the product to each wart Cover affected area with clean bandage Repeat procedure daily as needed (until wart is removed) for up to 12 weeks

⚠️ Warnings 75 words ▾

Warnings For external use only. Do not use if you are a diabetic on irritated, infected, or reddened skin if you have poor blood circulation on warts with hair growing from them on moles or birthmarks on face, genitals, or mucous membranes Stop use and ask a doctor if irritation occurs or discomfort persists Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 11 words ▾

Other Information Replace cap when finished and store at room temperature

🧪 Active Ingredient 6 words ▾

Active Ingredient Salicylic acid 40% (w/w)

🧪 Inactive Ingredients 9 words ▾

Inactive Ingredients Castor oil, chlorobutanol, paraffin, rosin, yellow wax

🎯 Purpose 3 words ▾

Purpose Wart remover

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

🔗 Related NDC lookups

🧪 All Salicylic Acid NDCsSame ingredient 🏭 All Balassa labeler NDCsLabeler code 10107 📖 Read the Salicylic Acid drug informationUses, warnings & side effects